Author: Avalon Health Economics LLC

The Coronavirus: How Bad is it, Really?
March 13, 2020 - 4:06 pm, by
By: The Avalon Health Economics Team March 13, 2020 Within a few months we’ve gone from worrying about holiday shopping to worrying about global pandemics and watching the world shut down around us. It started with news from China on the rapid spread of an insidious virus initially called a coronavirus.[1] Once the virus was...
What is the Reasonable Value of Future Medical Care?
February 10, 2020 - 1:49 pm, by
Cara Scheibling and John Schneider, PhD February 7, 2020 A common challenge in economics and business is determining the fair-market value of products and services that have not yet “entered” the market.  If consumers have not yet signaled a “willingness to pay” for the product or service, it is difficult to predict the fair market...
How Important is ICER Preparation and Review for U.S. Market Access?
December 23, 2019 - 3:13 pm, by
John Schneider, PhD and Alexis Doyle, MA Avalon Health Economics December 23, 2019 In recent years in the U.S., there has been an increase in the use of cost-effectiveness analysis (CEA) for drug and medical device coverage decisions. While the Center for Medicare and Medicaid Services (CMS) remains considerably behind European countries in the use...
Avalon Health Economics Will Be At ISPOR Copenhagen 2019
October 16, 2019 - 1:19 pm, by
Avalon Health Economics will be at ISPOR Copenhagen November 2nd-6th. Let us know if you will be there and want to set up a meeting! For more information, please visit the ISPOR website.
Avalon Health Economics will be at ISPOR New Orleans, May 18 through May 22, 2019
March 14, 2019 - 5:03 pm, by
Avalon Health Economics will be at ISPOR New Orleans, May 18 through May 22. We will be engaged in our usual array of posters, podium presentations, and short courses. If you are planning on attending, please let us know if you want to meet with any of our team!
Avalon Health Economics Collaborates with Acaster-LLoyd Consulting, Ltd.
December 26, 2018 - 12:36 pm, by
Avalon Health Economics is happy to announce an exciting new collaboration with the London-based Acaster-Lloyd Consulting, Ltd. Acaster-Lloyd, led by Sarah Acaster and Andrew Lloyd, is a leader in the area of clinical outcomes assessment (COA), including patient-reported outcomes, health-state utilities, strategy & analysis, preference surveys, instrument development, and qualitative research. The collaboration helps AHE...
Avalon Health Economics will be at ISPOR Barcelona, Nov. 10 through Nov. 14
September 28, 2018 - 11:31 am, by
Avalon Health Economics will be at ISPOR Barcelona, Nov. 10 through Nov. 14.  We will be engaged in our usual array of posters, podium presentations, and short courses.  If you are planning on attending, please let us know if you want to meet with any of our team!
Avalon will be attending AdvaMed in Philadelphia this September 24th-26th
May 9, 2018 - 9:52 am, by
Avalon will be attending AdvaMed in Philadelphia this September 24th-26th. To schedule meetings with the Avalon team, contact Nicole Nelson at nicole.nelson@avalonecon.com.
AHE Presents: Symposium on Emerging Trends in U.S. Health Economic Evaluation
February 1, 2018 - 12:16 pm, by
AHE Presents: Symposium on Emerging Trends in U.S. Health Economic Evaluation: A Closer Look at the Role of Cost Effectiveness in U.S. Market Access, Tuesday May 9th in Morristown, NJ
CEO John Schneider will be speaking at Research! America’s Medical Innovation 101 February briefing on Capitol Hill
January 6, 2018 - 12:14 pm, by
CEO John Schneider will be speaking at Research! America’s Medical Innovation 101 February briefing on Capitol Hill with Dr. Keith R. Yamamoto, Director of Precision Medicine at the University of California San Francisco, Dr. Joe V. Selby, Executive Director at PCORI, and others.
Do NOT follow this link or you will be banned from the site!